Plant Used in 60% to 80% of European Cancer Patients

13 He that answereth a matter before he heareth it, it is folly and shame unto him. ~ Proverbs 18:13 KJV

Plant Used in 60% to 80% of European Cancer Patients

Growing wild on tree branches around the world, this unusual plant has been used for thousands of years for pain, rheumatism, epilepsy and more. About 100 years ago, a famous philosopher noticed it looked a lot like a tumor – a keen observation that has transformed care for malignancies. ~ Mercola.com

____________________________

Analysis by Dr. Joseph Mercola / Fact Checked

May 31, 2022

With 100 years of continuous use and backed by 250 randomized studies, it is the most studied integrative oncology therapy in the world – and utilized in upward of 60% to 80% of patients in Europe.

Read Full PDF DrJosephMercola-DrNashaWinters-Mistletoe-AnEmergingAdjuncttoOncologicalTreatment

STORY AT-A-GLANCE

• Mistletoe, a semi-parasitic plant that grows in the branches of trees all over the world, has been used in herbal medicine for thousands of years for conditions such as epilepsy, spleen disorders, pain and rheumatic conditions
• In 1917, Rudolf Steiner, a philosopher with keen observation skills, noticed that mistletoe looks a lot like a tumor, and proposed it might have anticancer properties. Dr. Ita Wegman confirmed Steiner’s suspicion, and the plant has since enjoyed over 100 years of consistent application in oncology, both standalone and as adjuvant support
• Intravenous or subcutaneous mistletoe appears beneficial as an adjunct therapy for all cancers, and there are no drug or health contraindications. Even the most toxic treatments work better and with fewer adverse effects when combined with mistletoe
• Mistletoe is the most studied integrative oncology therapy in the world, and it is utilized in upward of 60% to 80% of all cancer patients in Europe
• Your immune system and metabolic function are both integral parts of addressing cancer, and mistletoe works on both

In this interview, Dr. Nasha Winters, co-author of “Mistletoe and the Emerging Future of Integrative Oncology,” reviews some of the benefits of this ancient herb in the modern world of oncology. Winters is herself a cancer survivor, so this topic is close to her heart.

“I’m coming on 30 years out of a death sentence, a terminal cancer diagnosis,” she says, “and still to this day get met with so much resistance to what I’ve learned for myself, and for thousands, if not tens of thousands, of other patients directly, as well as way more than that, indirectly, through the training of their physicians …

My crazy controversy is that I focus more on the human organism and the health of that terrain versus the condition, the disease or the label that overlays that person.”

View the Video Interview and read the full article at this LINK.